Product Information

ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by Major Pharmaceuticals, priced at $0.5727 per EA under NDC 00904705699. Its NADAC has been published 210 times since Jun 22, 2022.

ASPIRIN-DIPYRIDAM ER 25-200 MG

Aspirin and Extended - Release Dipyridamole
$0.5727per EA

Strength

25; 200 mg/1; mg/1

NDC

00904705699

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ASPIRIN; DIPYRIDAMOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA207944

On Market Since

1/30/2017

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor
Platelet Aggregation Inhibitor

Price Statistics

The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 210 times since Jun 22, 2022, and over the history we have for it it has declined 35.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5727 per EA
All-time high$0.8911 (Jul 13, 2022)
All-time low$0.5561 (Mar 18, 2026)
52-week high$0.6072
52-week low$0.5561
Median price$0.6667
Average price$0.6872
Largest weekly change+31.1% (Jun 19, 2024)
Weeks tracked210
Tracking sinceJun 22, 2022

Price History

1W

0.0%

1M

-0.0%

3M

+3.0%

6M

-5.7%

1Y

-1.7%

3Y

-20.3%

5Y

N/A

All

-35.7%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?

The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by Major Pharmaceuticals, is $0.5727 per EA (NDC 00904705699), effective Jun 24, 2026.

How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?

Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 35.7%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.

What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?

Since Jun 22, 2022, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $0.8911 (Jul 13, 2022), with a median of $0.6667 per EA.

Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as ASPIRIN-DIPYRIDAM ER 25-200 MG, but none are currently priced below it.

Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?

ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 00904705699) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.